Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 4, 2011, Pages 363-370

  Grady, Benjamin J ^a   Samuels, David C ^a   Robbins, Gregory K ^b   Selph, Doug ^a   Canter, Jeffrey A ^a   Pollard, Richard B ^c   Haas, David W ^d   Shafer, Robert ^e   Kalams, Spyros A ^d   Murdock, Deborah G ^a   Ritchie, Marylyn D ^a   Hulgan, Todd ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antiretroviral therapy; CD4 count; HIV; mitochondrial DNA; pharmacogenetics

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; MITOCHONDRIAL DNA; NELFINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BASE PAIRING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DNA SEQUENCE; DOUBLE BLIND PROCEDURE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGRO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; BASE SEQUENCE; BENZOXAZINES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FEMALE; GENOME, MITOCHONDRIAL; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NELFINAVIR; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 80255132953     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822c688b     Document Type: Article

References (35)

1. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360:1815-1826.
2. Gutierrez F, Padilla S, Masia M, et al. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: longterm follow-up of a multicenter cohort. PLoS One. 2006;1:e89.
3. Grabar S, Le MV, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med. 2000;133:401-410.
4. Haas DW, Geraghty DE, Andersen J, et al. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: an AIDS Clinical Trials Group Study. J Infect Dis. 2006;194:1098-1107. (Pubitemid 44547649)
5. Pvvetit F, Arnoult D, Viollet L, et al. Intrinsic and extrinsic pathways signaling during HIV-1 mediated cell death. Biochimie. 2003;85:795-811. (Pubitemid 37383799)
6. Varbanov M, Espert L, Biard-Piechaczyk M. Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins. AIDS Rev. 2006;8:221-236. (Pubitemid 46138920)
7. Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene. 1999;238:211-230. (Pubitemid 29436110)
8. van der Walt J, Nicodemus KK, Martin E, et al.Mitochondrial polymorphisms significantly reduce the risk of parkinson disease. Am J Hum Genet. 2003;72: 804-811. (Pubitemid 36403301)
9. Autere J, Moilanen JS, Finnila S, et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum Genet. 2004;115:29-35. (Pubitemid 38787215)
10. Castro MG, Huerta C, Reguero JR, et al. Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol. 2006;112:202-206. (Pubitemid 44354968)
11. De BG, Rose G, Carrieri G, et al. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J. 1999;13:1532-1536. (Pubitemid 29411786)
12. Niemi AK, Hervonen A, Hurme M, et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet. 2003;112:29-33. (Pubitemid 36869112)
13. Canter JA, Robbins GK, Selph D, et al. African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy. J Infect Dis. 2010;201:1703-1707.
14. Hulgan T, Haubrich R, Riddler SA, et al. European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. AIDS. 2011;25:37-47.
15. Robbins GK, De GV, Shafer RW, et al. Comparison of sequential threedrug regimens as initial therapy for HIV-1 infection. N Engl J Med. 2003; 349:2293-2303. (Pubitemid 37509737)
16. Gandhi RT, Spritzler J, Chan E, et al. Effect of baseline-and treatmentrelated factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006;42:426-434. (Pubitemid 44050889)
17. Haas DW, Wilkinson GR, Kuritzkes DR, et al. A multi-investigator/ institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128. HIV Clin Trials. 2003;4:287-300. (Pubitemid 37304432)
18. Kallianpur AR, Hulgan T, Canter JA, et al. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS. 2006;20:1503-1513. (Pubitemid 44100211)
19. Motsinger AA, Ritchie MD, Shafer RW, et al. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics. 2006;16:837-845. (Pubitemid 44632298)
20. Hulgan T, Haas DW, Haines JL, et al. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS. 2005;19:1341-1349. (Pubitemid 41800669)
21. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457-465. (Pubitemid 11159074)
22. Herrnstadt C, Elson JL, Fahy E, et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet. 2002;70: 1152-1171. (Pubitemid 34450567)
23. Hadi AS. Identifying multiple outliers in multivariate data. J R Stat Soc. 1992;54:761-771.
24. Grady BJ, Torstenson E, Dudek SM, et al. Finding unique filter sets in plato: a precursor to efficient interaction analysis in gwas data. Pac Symp Biocomput. 2010;15:315-326.
25. Little J, Sharp L, Khoury MJ, et al. The epidemiologic approach to pharmacogenomics. Am J Pharmacogenomics. 2005;5:1-20. (Pubitemid 40803828)
26. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575. (Pubitemid 47330214)
27. van Buuren S, Oudshoorn C. MICE: Multivariate Imputation by Chained Equations. R package version 2.3. Available at: http://cran.r-project.org/web/ packages/mice/index.html. Accessed May 14, 2010.
28. van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009;30:E386-E394.
29. Garg H, Blumenthal R. HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir. J Leukoc Biol. 2006;79:351-362. (Pubitemid 44831167)
30. Peraire J, Miro O, Saumoy M, et al. HIV-1-infected long-term nonprogressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressors. Curr HIV Res. 2007;5:467-473.
31. Wang J, Silva JP, Gustafsson CM, et al. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci USA. 2001;98:4038-4043. (Pubitemid 32249894)
32. Mirabella M, Di GS, Silvestri G, et al. Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain. 2000;123(Pt 1):93-104. (Pubitemid 30037972)
33. Sciacco M, Fagiolari G, Lamperti C, et al. Lack of apoptosis in mitochondrial encephalomyopathies. Neurology. 2001;56:1070-1074. (Pubitemid 32336315)
34. Geromel V, Kadhom N, Cebalos-Picot I, et al. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet. 2001;10:1221-1228. (Pubitemid 32487545)
35. Hendrickson SL, Hutcheson HB, Ruiz-Pesini E, et al. Mitochondrial DNA haplogroups influence AIDS progression. AIDS. 2008;22:2429-2439.